We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00478582
First Posted: May 25, 2007
Last Update Posted: January 13, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital Inselspital, Berne
  Purpose

The clinical evaluation of anemia is usually done by examination of the palpebral conjontivae coloration. This appreciation remains crude and largely observer dependent, as no reference scale was successfully proposed,. A Hb visual scale allowing the assessment of the degree of clinical anemia has been developed. Its use has been validated so far in small patient groups in the following settings: blood donation, cardiac surgery, oncology and consultation of general practitioners.

The objective of the present investigation is to validate the use of a Hb visual scale for the clinical evaluation of anemia in patients with kidney disease patients


Condition Intervention
Anemia Procedure: Estimation of Hb concentrations with the HemoHue card

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Diagnostic
Official Title: Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients

Resource links provided by NLM:


Further study details as provided by University Hospital Inselspital, Berne:

Primary Outcome Measures:
  • Comparison of visual estimated Hb concentrations with measured Hb concentrations

Study Start Date: May 2007
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with chronich kidney disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00478582


Locations
Switzerland
Department of nephrology and hypertension, University hospital of berne
Berne, Switzerland, 3010
Sponsors and Collaborators
University Hospital Inselspital, Berne
Investigators
Study Director: Dominik Uehlinger, Prof
Principal Investigator: Dominik Uelinger, Prof
  More Information

ClinicalTrials.gov Identifier: NCT00478582     History of Changes
Other Study ID Numbers: HB 5/2007
First Submitted: May 24, 2007
First Posted: May 25, 2007
Last Update Posted: January 13, 2011
Last Verified: January 2011

Keywords provided by University Hospital Inselspital, Berne:
Anemia
Visual scale
nephrological patients
Anemia in nephrological patients

Additional relevant MeSH terms:
Anemia
Hematologic Diseases